INTERPACE BIOSCIENCES, INC.
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.
On December 7, 2023, Robert Gorman, a Class II director designated by Ampersand 2018 Limited Partnership to the board of directors (the “ Board ”) of Interpace Biosciences, Inc. (the “ Company ”), provided notice to the Company of his resignation as a director and as Chairman of the Board, including as a member of the Board’s Regulatory Compliance Committee, effective immediately.
Extracted from this filing and checked against the source text.
Robert Gorman resigned as Director and Chairman at INTERPACE BIOSCIENCES, INC..
On December 7, 2023, Robert Gorman, a Class II director designated by Ampersand 2018 Limited Partnership to the board of directors (the “ Board ”) of Interpace Biosciences, Inc. (the “ Company ”), provided notice to the Company of his resignation as a director and as Chairman of the Board, including as a member of the Board’s Regulatory Compliance Committee, effective immediately.View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.